Functional	O
roles	O
of	O
in	B-DNA
vivo	I-DNA
footprinted	I-DNA
DNA	I-DNA
motifs	I-DNA
within	O
an	O
alpha-globin	B-DNA
enhancer	I-DNA
.	O

Erythroid	O
lineage	O
and	O
developmental	O
stage	O
specificities	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
human	B-DNA
alpha-like	I-DNA
globin	I-DNA
genes	I-DNA
,	O
embryonic	B-DNA
zeta	I-DNA
2	I-DNA
and	O
adult	B-DNA
alpha	I-DNA
,	O
during	O
erythroid	O
development	O
is	O
mediated	O
by	O
a	O
distal	B-DNA
enhancer	I-DNA
,	O
HS-40	B-DNA
.	O

Previous	O
protein-DNA	O
binding	O
studies	O
have	O
shown	O
that	O
HS-40	B-DNA
consists	O
of	O
multiple	O
nuclear	B-DNA
factor	I-DNA
binding	I-DNA
motifs	I-DNA
that	O
are	O
occupied	O
in	O
vivo	O
in	O
an	O
erythroid	O
lineage-	O
and	O
developmental	O
stage-specific	O
manner	O
.	O

We	O
have	O
systematically	O
analyzed	O
the	O
functional	O
roles	O
of	O
these	O
factor	B-DNA
binding	I-DNA
motifs	I-DNA
of	O
HS-40	B-DNA
by	O
site-directed	O
mutagenesis	O
and	O
transient	O
expression	O
assay	O
in	O
erythroid	B-cell_line
cell	I-cell_line
cultures	I-cell_line
.	O

Three	O
of	O
these	O
HS-40	B-DNA
enhancer	I-DNA
motifs	I-DNA
,	O
5'NF-E2/AP1	B-DNA
,	O
GT	B-DNA
II	I-DNA
,	O
and	O
GATA-1	B-DNA
(	I-DNA
c	I-DNA
)	I-DNA
,	O
positively	O
regulate	O
the	O
zeta	B-DNA
2-globin	I-DNA
promoter	I-DNA
activity	O
in	O
embryonic/fetal	B-cell_line
erythroid	I-cell_line
K562	I-cell_line
cells	I-cell_line
and	O
the	O
adult	B-DNA
alpha-globin	I-DNA
promoter	I-DNA
activity	O
in	O
adult	B-cell_line
erythroid	I-cell_line
MEL	I-cell_line
cells	I-cell_line
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
3'NF-E2/AP1	B-DNA
motif	I-DNA
is	O
able	O
to	O
exert	O
both	O
positive	O
and	O
negative	O
regulatory	O
effects	O
on	O
the	O
zeta	B-DNA
2-globin	I-DNA
promoter	I-DNA
activity	O
in	O
K562	B-cell_line
cells	I-cell_line
,	O
and	O
this	O
dual	O
function	O
appears	O
to	O
be	O
modulated	O
through	O
differential	O
binding	O
of	O
the	O
ubiquitous	B-protein
AP1	I-protein
factors	I-protein
and	O
the	O
erythroid-enriched	B-protein
NF-E2	I-protein
factor	I-protein
.	O

Mutation	O
in	O
the	O
GATA-1	B-DNA
(	I-DNA
d	I-DNA
)	I-DNA
motif	I-DNA
,	O
which	O
exhibits	O
an	O
adult	B-DNA
erythroid-specific	I-DNA
genomic	I-DNA
footprint	I-DNA
,	O
decreases	O
the	O
HS-40	B-DNA
enhancer	I-DNA
function	O
in	O
dimethyl	B-cell_line
sulfoxide-induced	I-cell_line
MEL	I-cell_line
cells	I-cell_line
but	O
not	O
in	O
K562	B-cell_line
cells	I-cell_line
.	O

These	O
studies	O
have	O
defined	O
the	O
regulatory	O
roles	O
of	O
the	O
different	O
HS-40	B-DNA
motifs	I-DNA
.	O

The	O
remarkable	O
correlation	O
between	O
genomic	O
footprinting	O
data	O
and	O
the	O
mutagenesis	O
results	O
also	O
suggests	O
that	O
the	O
erythroid	O
lineage-	O
and	O
developmental	O
stage-specific	O
regulation	O
of	O
human	B-DNA
alpha-like	I-DNA
globin	I-DNA
promoters	I-DNA
is	O
indeed	O
modulated	O
by	O
stable	O
binding	O
of	O
specific	B-protein
nuclear	I-protein
factors	I-protein
in	O
vivo	O
.	O

THE	NULL
JourNaL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

15	NULL
,	NULL
Issue	NULL
of	NULL
April	NULL
14	NULL
,	NULL
pp	NULL
.	NULL

8501-8505	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Functional	NULL
Roles	NULL
of	NULL
in	NULL
Vivo	NULL
Footprinted	NULL
DNA	NULL
Motifs	NULL
within	NULL
an	NULL
«	NULL
-Globin	NULL
Enhancer	NULL
ERYTHROID	NULL
LINEAGE	NULL
AND	NULL
DEVELOPMENTAL	NULL
STAGE	NULL
SPECIFICITIES*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
23	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
January	NULL
31	NULL
,	NULL
1995	NULL
)	NULL
Qingyi	NULL
Zhang	NULL
,	NULL
Irene	NULL
Rombel	NULL
,	NULL
G.	NULL
Narender	NULL
Reddy	NULL
,	NULL
Jong-Back	NULL
Gang	NULL
,	NULL
and	NULL
C.-K.	NULL
James	NULL
Shent	NULL
From	NULL
the	NULL
Section	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Davis	NULL
,	NULL
California	NULL
95616	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
«	NULL
-like	NULL
globin	NULL
genes	NULL
,	NULL
embryonic	NULL
{	NULL
2	NULL
and	NULL
adult	NULL
a	NULL
,	NULL
during	NULL
erythroid	NULL
development	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
distal	NULL
enhancer	NULL
,	NULL
HS-40	NULL
.	NULL

Previous	NULL
protein-DNA	NULL
binding	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
HS-40	NULL
consists	NULL
of	NULL
multiple	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
that	NULL
are	NULL
occupied	NULL
in	NULL
vivo	NULL
in	NULL
an	NULL
erythroid	NULL
lineage-	NULL
and	NULL
developmental	NULL
stage-specific	NULL
manner	NULL
.	NULL

We	NULL
have	NULL
systematically	NULL
analyzed	NULL
the	NULL
functional	NULL
roles	NULL
of	NULL
these	NULL
factor	NULL
binding	NULL
motifs	NULL
of	NULL
HS-40	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
and	NULL
transient	NULL
expression	NULL
assay	NULL
in	NULL
erythroid	NULL
cell	NULL
cultures	NULL
.	NULL

Three	NULL
of	NULL
these	NULL
HS-40	NULL
enhancer	NULL
motifs	NULL
,	NULL
AP1	NULL
,	NULL
GT	NULL
II	NULL
,	NULL
and	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
,	NULL
positively	NULL
regulate	NULL
the	NULL
{	NULL
(	NULL
2-globin	NULL
promoter	NULL
activity	NULL
in	NULL
embryonic/fetal	NULL
erythroid	NULL
K562	NULL
cells	NULL
and	NULL
the	NULL
adult	NULL
a-globin	NULL
promoter	NULL
activity	NULL
in	NULL
adult	NULL
erythroid	NULL
MEL	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
3'NF-E2/AP1	NULL
motif	NULL
is	NULL
able	NULL
to	NULL
exert	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
effects	NULL
on	NULL
the	NULL
{	NULL
2-globin	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
dual	NULL
function	NULL
appears	NULL
to	NULL
be	NULL
modulated	NULL
through	NULL
differential	NULL
binding	NULL
of	NULL
the	NULL
ubiquitous	NULL
API	NULL
factors	NULL
and	NULL
the	NULL
erythroid-enriched	NULL
NF-E2	NULL
factor	NULL
.	NULL

Mutation	NULL
in	NULL
the	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
motif	NULL
,	NULL
which	NULL
exhibits	NULL
an	NULL
adult	NULL
erythroid-specific	NULL
genomic	NULL
footprint	NULL
,	NULL
decreases	NULL
the	NULL
HS-40	NULL
enhancer	NULL
function	NULL
in	NULL
dimethyl	NULL
sulfoxide-induced	NULL
MEL	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

These	NULL
studies	NULL
have	NULL
defined	NULL
the	NULL
regulatory	NULL
roles	NULL
of	NULL
the	NULL
different	NULL
HS-40	NULL
motifs	NULL
.	NULL

The	NULL
remarkable	NULL
correlation	NULL
between	NULL
genomic	NULL
footprinting	NULL
data	NULL
and	NULL
the	NULL
mutagenesis	NULL
results	NULL
also	NULL
suggests	NULL
that	NULL
the	NULL
erythroid	NULL
lineage-	NULL
and	NULL
developmental	NULL
stage-specific	NULL
regulation	NULL
of	NULL
human	NULL
«	NULL
-like	NULL
globin	NULL
promoters	NULL
is	NULL
indeed	NULL
modulated	NULL
by	NULL
stable	NULL
binding	NULL
of	NULL
specific	NULL
nuclear	NULL
factors	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
human	NULL
«	NULL
-like	NULL
globin	NULL
gene	NULL
family	NULL
is	NULL
clustered	NULL
on	NULL
chromosome	NULL
16	NULL
.	NULL

The	NULL
transcriptionally	NULL
active	NULL
members	NULL
of	NULL
the	NULL
gene	NULL
cluster	NULL
are	NULL
arranged	NULL
in	NULL
the	NULL
order	NULL
of	NULL
their	NULL
expression	NULL
during	NULL
erythroid	NULL
development	NULL
:	NULL
5'-	NULL
{	NULL
2	NULL
(	NULL
embryonic	NULL
)	NULL
>	NULL
-a2	NULL
(	NULL
fetal/adult	NULL
)	NULL
-a1	NULL
(	NULL
fetal/adult	NULL
)	NULL
-91	NULL
(	NULL
fetal/adult	NULL
,	NULL
minor	NULL
)	NULL
-3	NULL
'	NULL
(	NULL
Higgs	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Of	NULL
these	NULL
members	NULL
,	NULL
£2	NULL
is	NULL
transcribed	NULL
predominantly	NULL
in	NULL
yolk	NULL
sac	NULL
,	NULL
the	NULL
embryonic	NULL
erythroid	NULL
tissue	NULL
.	NULL

As	NULL
development	NULL
proceeds	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
£2	NULL
is	NULL
shut	NULL
off	NULL
,	NULL
and	NULL
the	NULL
two	NULL
«	NULL
-globin	NULL
genes	NULL
,	NULL
«	NULL
2	NULL
and	NULL
al	NULL
,	NULL
are	NULL
turned	NULL
on	NULL
in	NULL
fetal	NULL
liver	NULL
.	NULL

Finally	NULL
,	NULL
in	NULL
adult	NULL
humans	NULL
,	NULL
the	NULL
two	NULL
a-globin	NULL
genes	NULL
are	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
nucleated	NULL
erythroblasts	NULL
originated	NULL
from	NULL
appropriate	NULL
stem	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
.	NULL

In	NULL
the	NULL
adult	NULL
and	NULL
fetal	NULL
erythroblasts	NULL
,	NULL
however	NULL
,	NULL
low	NULL
levels	NULL
of	NULL
{	NULL
2	NULL
and	NULL
01	NULL
messages	NULL
could	NULL
still	NULL
be	NULL
detected	NULL
(	NULL
Albitar	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Chui	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
these	NULL
«	NULL
-like	NULL
*	NULL
This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
DK-29800	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

¢	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
916-752-8860	NULL
;	NULL
Fax	NULL
:	NULL
916-752-3085.	NULL
globin	NULL
genes	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
B-like	NULL
globin	NULL
family	NULL
members	NULL
,	NULL
is	NULL
regulated	NULL
predominantly	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
Collins	NULL
and	NULL
Weissman	NULL
,	NULL
1984	NULL
;	NULL
Karlsson	NULL
and	NULL
Nienhuis	NULL
,	NULL
1985	NULL
)	NULL
.	NULL

Both	NULL
genetic	NULL
and	NULL
molecular	NULL
data	NULL
(	NULL
Higgs	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
have	NULL
indicated	NULL
that	NULL
the	NULL
appropriate	NULL
erythroid	NULL
lineage-	NULL
and	NULL
developmental	NULL
stage-specific	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
«	NULL
-like	NULL
globin	NULL
gene	NULL
family	NULL
is	NULL
,	NULL
like	NULL
the	NULL
B-like	NULL
globin	NULL
family	NULL
(	NULL
Orkin	NULL
,	NULL
1990	NULL
;	NULL
Stamatoyannopoulos	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
modulated	NULL
by	NULL
the	NULL
so-called	NULL
locus	NULL
control	NULL
region	NULL
(	NULL
LCR	NULL
)	NULL
.	NULL

The	NULL
a-LCR	NULL
is	NULL
located	NULL
at	NULL
approximately	NULL
40	NULL
kilobase	NULL
pairs	NULL
upstream	NULL
of	NULL
the	NULL
{	NULL
2-globin	NULL
gene	NULL
,	NULL
and	NULL
its	NULL
functional	NULL
domain	NULL
has	NULL
been	NULL
mapped	NULL
,	NULL
by	NULL
transgenic	NULL
mice	NULL
and	NULL
DNA	NULL
transfection	NULL
studies	NULL
,	NULL
to	NULL
a	NULL
300-bp	NULL
sequence	NULL
containing	NULL
an	NULL
erythroid-specific	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
(	NULL
HS-40	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
B-like	NULL
globin	NULL
genes	NULL
by	NULL
B-LCR	NULL
,	NULL
the	NULL
a-LCR	NULL
or	NULL
HS-40	NULL
confers	NULL
high	NULL
levels	NULL
of	NULL
erythroid-specific	NULL
expression	NULL
of	NULL
linked	NULL
human	NULL
{	NULL
2-	NULL
or	NULL
«	NULL
-globin	NULL
genes	NULL
in	NULL
transgenic	NULL
mice	NULL
or	NULL
stably	NULL
integrated	NULL
cell	NULL
lines	NULL
(	NULL
Jarman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Sharpe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Vyas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Sharpe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Gourdon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

It	NULL
also	NULL
behaves	NULL
as	NULL
a	NULL
classical	NULL
enhancer	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
{	NULL
2-	NULL
or	NULL
«	NULL
-globin	NULL
genes	NULL
in	NULL
transiently	NULL
transfected	NULL
erythroid	NULL
cell	NULL
culture	NULL
(	NULL
Pondel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ren	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
of	NULL
how	NULL
the	NULL
a-LCR	NULL
controls	NULL
£2-	NULL
or	NULL
«	NULL
-globin	NULL
gene	NULL
transcription	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

By	NULL
analogy	NULL
to	NULL
what	NULL
have	NULL
been	NULL
hypothesized	NULL
for	NULL
the	NULL
B-LCR	NULL
function	NULL
(	NULL
Grosveld	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Evans	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Forrester	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Engel	NULL
,	NULL
1993	NULL
)	NULL
,	NULL
the	NULL
«	NULL
-LCR	NULL
could	NULL
play	NULL
a	NULL
dominant	NULL
role	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
active	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
entire	NULL
a-like	NULL
globin	NULL
locus	NULL
domain	NULL
.	NULL

It	NULL
could	NULL
also	NULL
,	NULL
like	NULL
other	NULL
eukaryotic	NULL
gene	NULL
enhancers	NULL
,	NULL
facilitate	NULL
the	NULL
assembly	NULL
of	NULL
active	NULL
transcriptional	NULL
initiation	NULL
complexes	NULL
at	NULL
the	NULL
{	NULL
2-	NULL
or	NULL
-globin	NULL
upstream	NULL
promoters	NULL
.	NULL

All	NULL
of	NULL
these	NULL
regulatory	NULL
processes	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
modulated	NULL
by	NULL
diffusible	NULL
nuclear	NULL
factors	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
previous	NULL
chromosome	NULL
transfer	NULL
and	NULL
cell	NULL
fusion	NULL
experiments	NULL
(	NULL
Deisseroth	NULL
and	NULL
Hendrick	NULL
,	NULL
1979	NULL
;	NULL
Baron	NULL
and	NULL
Maniatis	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

A	NULL
number	NULL
of	NULL
nuclear	NULL
factors	NULL
bind	NULL
in	NULL
vitro	NULL
to	NULL
several	NULL
different	NULL
sequence	NULL
motifs	NULL
of	NULL
the	NULL
«	NULL
-LCR	NULL
(	NULL
Jarman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Strauss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Subsequent	NULL
genomic	NULL
footprinting	NULL
work	NULL
has	NULL
demonstrated	NULL
the	NULL
formation	NULL
in	NULL
vivo	NULL
of	NULL
specific	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
at	NULL
a	NULL
subset	NULL
of	NULL
these	NULL
sequence	NULL
motifs	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
Strauss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
single	NULL
set	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
is	NULL
found	NULL
in	NULL
the	NULL
«	NULL
-LCR	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
B-LCR	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

These	NULL
motifs	NULL
include	NULL
GATA-1	NULL
,	NULL
which	NULL
binds	NULL
a	NULL
factor	NULL
specifically	NULL
expressed	NULL
in	NULL
erythroid	NULL
,	NULL
megakaryotic	NULL
,	NULL
and	NULL
mast	NULL
cell	NULL
lineages	NULL
(	NULL
Martin	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Romeo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
;	NULL
the	NULL
NF-E2/AP1	NULL
motif	NULL
that	NULL
can	NULL
bind	NULL
either	NULL
NF-E2	NULL
,	NULL
which	NULL
has	NULL
a	NULL
similar	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
expression	NULL
as	NULL
GATA-1	NULL
,	NULL
or	NULL
the	NULL
widely	NULL
expressed	NULL
API	NULL
factor	NULL
(	NULL
Andrews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
,	NULL
1993b	NULL
;	NULL
Chan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Caterina	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Igarashi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
;	NULL
and	NULL
the	NULL
GT	NULL
*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
LCR	NULL
,	NULL
locus	NULL
control	NULL
region	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
Me	NULL
,	NULL
SO	NULL
,	NULL
dimethyl	NULL
sulfoxide	NULL
;	NULL
GH	NULL
,	NULL
growth	NULL
hormone	NULL
.	NULL

8501	NULL
8502	NULL
motif	NULL
,	NULL
which	NULL
binds	NULL
Sp1	NULL
,	NULL
USF	NULL
,	NULL
or	NULL
TEF	NULL
(	NULL
Jarman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
contributions	NULL
of	NULL
these	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
to	NULL
the	NULL
enhancement	NULL
of	NULL
human	NULL
embryonic	NULL
{	NULL
2-globin	NULL
promoter	NULL
activity	NULL
by	NULL
HS-40	NULL
have	NULL
been	NULL
partially	NULL
analyzed	NULL
before	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
results	NULL
suggested	NULL
that	NULL
one	NULL
of	NULL
the	NULL
four	NULL
GATA-1	NULL
motifs	NULL
,	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
and	NULL
both	NULL
NF-E2/AP1	NULL
motifs	NULL
played	NULL
positive	NULL
regulatory	NULL
roles	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mutant	NULL
HS-40	NULL
sequences	NULL
used	NULL
in	NULL
the	NULL
above	NULL
study	NULL
were	NULL
generated	NULL
mainly	NULL
by	NULL
Bal31	NULL
deletion	NULL
,	NULL
which	NULL
could	NULL
remove	NULL
more	NULL
than	NULL
one	NULL
functional	NULL
motif	NULL
during	NULL
successive	NULL
deletion	NULL
steps	NULL
.	NULL

This	NULL
would	NULL
have	NULL
prohibited	NULL
the	NULL
definitive	NULL
assignment	NULL
of	NULL
the	NULL
positive/	NULL
negative	NULL
role	NULL
of	NULL
a	NULL
particular	NULL
motif	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
previous	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
only	NULL
with	NULL
transfected	NULL
K562	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
erythroid	NULL
cell	NULL
line	NULL
of	NULL
embryonic/fetal	NULL
origins	NULL
(	NULL
Lozzio	NULL
and	NULL
Lozzio	NULL
,	NULL
1975	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
did	NULL
not	NULL
allow	NULL
us	NULL
to	NULL
assess	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
developmental	NULL
stage-specific	NULL
difference	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
patterns	NULL
within	NULL
HS-40	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
previous	NULL
genomic	NULL
footprinting	NULL
analysis	NULL
of	NULL
HS-40	NULL
in	NULL
adult	NULL
versus	NULL
embryonic/fetal	NULL
erythroid	NULL
cells	NULL
(	NULL
Strauss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

To	NULL
gain	NULL
further	NULL
insights	NULL
into	NULL
the	NULL
functions	NULL
of	NULL
the	NULL
multiple	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
of	NULL
HS-40	NULL
,	NULL
we	NULL
have	NULL
generated	NULL
various	NULL
HS-40	NULL
mutants	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
either	NULL
the	NULL
embryonic	NULL
{	NULL
2-	NULL
or	NULL
the	NULL
adult	NULL
-globin	NULL
gene	NULL
promoter	NULL
cis-linked	NULL
to	NULL
these	NULL
HS-40	NULL
mutants	NULL
was	NULL
then	NULL
assayed	NULL
after	NULL
transient	NULL
expression	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
in	NULL
MEL	NULL
,	NULL
a	NULL
mouse	NULL
adult	NULL
erythroid	NULL
cell	NULL
line	NULL
(	NULL
Friend	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1971	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
below	NULL
,	NULL
the	NULL
present	NULL
study	NULL
has	NULL
clearly	NULL
defined	NULL
the	NULL
positive/negative	NULL
roles	NULL
of	NULL
different	NULL
HS-40	NULL
DNA	NULL
motifs	NULL
,	NULL
including	NULL
a	NULL
dual	NULL
role	NULL
of	NULL
the	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
motif	NULL
.	NULL

The	NULL
functionality	NULL
of	NULL
these	NULL
motifs	NULL
also	NULL
correlates	NULL
remarkably	NULL
well	NULL
with	NULL
their	NULL
erythroid	NULL
lineage-	NULL
and	NULL
developmental	NULL
stage-specific	NULL
occupancies	NULL
by	NULL
nuclear	NULL
factors	NULL
in	NULL
vivo	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Plasmid	NULL
Constructs	NULL
and	NULL
Site-directed	NULL
Mutagenesis-We	NULL
first	NULL
constructed	NULL
pBlue-HS-40	NULL
by	NULL
blunt	NULL
end	NULL
ligation	NULL
of	NULL
a	NULL
373-bp	NULL
EcoRI-BamHI	NULL
fragment	NULL
containing	NULL
the	NULL
HS-40	NULL
enhancer	NULL
(	NULL
Higgs	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
pBluescript	NULL
II	NULL
KS	NULL
(	NULL
-	NULL
)	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
was	NULL
conducted	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
,	NULL
Mutator	NULL
``	NULL
``	NULL
``	NULL
site-directed	NULL
mutagenesis	NULL
kit	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Different	NULL
oligonucleotides	NULL
were	NULL
designed	NULL
and	NULL
synthesized	NULL
so	NULL
that	NULL
they	NULL
were	NULL
homologous	NULL
to	NULL
specific	NULL
target	NULL
regions	NULL
in	NULL
the	NULL
wild	NULL
type	NULL
enhancer	NULL
but	NULL
with	NULL
one	NULL
or	NULL
more	NULL
base	NULL
mismatches	NULL
in	NULL
the	NULL
core	NULL
binding	NULL
sites	NULL
for	NULL
different	NULL
nuclear	NULL
factors	NULL
.	NULL

Many	NULL
of	NULL
them	NULL
also	NULL
contained	NULL
specific	NULL
restriction	NULL
enzyme	NULL
sites	NULL
in	NULL
order	NULL
to	NULL
facilitate	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
mutants	NULL
.	NULL

HS-40	NULL
mutations	NULL
were	NULL
first	NULL
introduced	NULL
into	NULL
the	NULL
plasmid	NULL
pBlue-HS-40	NULL
.	NULL

The	NULL
wild	NULL
type	NULL
and	NULL
different	NULL
HS-40	NULL
mutant-containing	NULL
fragments	NULL
were	NULL
then	NULL
isolated	NULL
from	NULL
agarose	NULL
gels	NULL
after	NULL
XbaI	NULL
digestion	NULL
of	NULL
pBlue-HS-40	NULL
or	NULL
the	NULL
above	NULL
pBlue-HS-40-based	NULL
plasmids	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Xbal	NULL
site	NULL
of	NULL
p-	NULL
{	NULL
597GH	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
597	NULL
bp	NULL
of	NULL
the	NULL
{	NULL
2-globin	NULL
promoter	NULL
region	NULL
(	NULL
-559	NULL
to	NULL
+38	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
human	NULL
growth	NULL
hormone	NULL
reporter	NULL
gene	NULL
in	NULL
pOGH	NULL
(	NULL
Nichols	NULL
Institute	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
enhancer	NULL
fragments	NULL
was	NULL
also	NULL
cloned	NULL
,	NULL
by	NULL
blunt	NULL
end	NULL
ligation	NULL
,	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
pB-	NULL
«	NULL
590GH	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
590-bp	NULL
HindIII-Ddel	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
a-globin	NULL
promoter	NULL
(	NULL
-574	NULL
to	NULL
+21	NULL
)	NULL
located	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
growth	NULL
hormone	NULL
gene	NULL
of	NULL
pOGH	NULL
.	NULL

Only	NULL
plasmids	NULL
containing	NULL
HS-40	NULL
in	NULL
the	NULL
genomic	NULL
orientation	NULL
relative	NULL
to	NULL
the	NULL
globin	NULL
promoters	NULL
were	NULL
used	NULL
in	NULL
the	NULL
transfection	NULL
assay	NULL
.	NULL

All	NULL
mutant	NULL
plasmids	NULL
were	NULL
identified	NULL
by	NULL
restriction	NULL
enzyme	NULL
cutting	NULL
and	NULL
dideoxynucleotide	NULL
sequencing	NULL
.	NULL

Corresponding	NULL
to	NULL
the	NULL
lower	NULL
strand	NULL
of	NULL
HS-40	NULL
,	NULL
the	NULL
mutant	NULL
oligonucleotides	NULL
used	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
are	NULL
:	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
,	NULL
5-GTTGGCCCA-GaatTCTGCTCCCTCAAGT-3	NULL
'	NULL
;	NULL
5'NF-E2	NULL
%	NULL
/AP1	NULL
,	NULL
5-CAGAAGCACTGA-tegATGGTTGGCCCAG-3	NULL
'	NULL
;	NULL
3	NULL
'	NULL
(	NULL
NF-E2/AP1	NULL
)	NULL
-I	NULL
,	NULL
5-CCCCCACAGGATega-TCAGCAGTCCTGT-3	NULL
'	NULL
``	NULL
;	NULL
3	NULL
'	NULL
(	NULL
NPF-E2	NULL
%	NULL
/AP1	NULL
}	NULL
-II	NULL
,	NULL
5-CCCCCACAGGATGAC-TCAGaAGTCCTGT-3	NULL
'	NULL
;	NULL
GT	NULL
II	NULL
,	NULL
5-CCCACCTCCACgtgCACAGGATGA-CTC-3	NULL
'	NULL
;	NULL
GATA-l	NULL
(	NULL
c	NULL
)	NULL
,	NULL
5-GCACCAGAGGTTGaatTCAGCAGTACCA-3	NULL
'	NULL
;	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
,	NULL
5-CTTCCCTCTCAGgTtAACAGGAGGGGGA-3	NULL
'	NULL
.	NULL

The	NULL
plasmids	NULL
containing	NULL
different	NULL
site-directed	NULL
mutants	NULL
are	NULL
named	NULL
according	NULL
to	NULL
the	NULL
following	NULL
examples	NULL
.	NULL

The	NULL
plasmids	NULL
containing	NULL
the	NULL
wild	NULL
type	NULL
HS-40	NULL
are	NULL
pHS-40-£597GH	NULL
and	NULL
pHS-40-B-a590GH	NULL
;	NULL
the	NULL
plasmids	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
5'NF-E2	NULL
%	NULL
/AP1	NULL
motif	NULL
of	NULL
HS-40	NULL
are	NULL
pHS-40	NULL
Positive	NULL
and	NULL
Negative	NULL
Control	NULL
of	NULL
Human	NULL
«	NULL
-Globin	NULL
Enhancer	NULL
HS-40	NULL
(	NULL
5'NF-E2/AP1	NULL
)	NULL
-	NULL
{	NULL
597GH	NULL
and	NULL
pB-HS-40	NULL
(	NULL
5NF-E2/AP1	NULL
)	NULL
-a590GH	NULL
,	NULL
etc	NULL
.	NULL

Transient	NULL
Transfection	NULL
Analysis-The	NULL
maintenance	NULL
of	NULL
the	NULL
erythroid	NULL
K562	NULL
and	NULL
MEL	NULL
cells	NULL
in	NULL
culture	NULL
is	NULL
as	NULL
described	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Reddy	NULL
and	NULL
Shen	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

DNA	NULL
transfection	NULL
was	NULL
accomplished	NULL
by	NULL
electroporation	NULL
(	NULL
Potter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
.	NULL

Procedures	NULL
for	NULL
transfection	NULL
of	NULL
K562	NULL
cells	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
previously	NULL
described	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
except	NULL
that	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
densities	NULL
of	NULL
5-8	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

It	NULL
was	NULL
observed	NULL
that	NULL
the	NULL
lower	NULL
densities	NULL
of	NULL
cells	NULL
at	NULL
harvesting	NULL
prior	NULL
to	NULL
the	NULL
electroporation	NULL
gave	NULL
more	NULL
reproducible	NULL
data	NULL
of	NULL
transient	NULL
expression	NULL
.	NULL

For	NULL
transient	NULL
expression	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
Me	NULL
,	NULL
SO	NULL
)	NULL
-induced	NULL
MEL	NULL
,	NULL
the	NULL
cells	NULL
growing	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
50	NULL
units/ml	NULL
penicillin	NULL
,	NULL
and	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
densities	NULL
of	NULL
1-5	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10	NULL
``	NULL
cells	NULL
was	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
resuspended	NULL
in	NULL
0.4	NULL
ml	NULL
of	NULL
medium	NULL
containing	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
test	NULL
plasmid	NULL
(	NULL
s	NULL
)	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
pSV2CAT	NULL
(	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
)	NULL
,	NULL
and	NULL
50	NULL
ug	NULL
of	NULL
sheared	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
media	NULL
with	NULL
2.5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
2	NULL
%	NULL
Me	NULL
,	NULL
SO	NULL
for	NULL
5	NULL
days	NULL
,	NULL
with	NULL
1:1	NULL
dilution	NULL
on	NULL
the	NULL
3rd	NULL
day	NULL
.	NULL

The	NULL
relatively	NULL
low	NULL
levels	NULL
of	NULL
globin	NULL
promoter	NULL
activities	NULL
from	NULL
enhancerless	NULL
plasmids	NULL
were	NULL
measured	NULL
by	NULL
the	NULL
sensitive	NULL
human	NULL
growth	NULL
hormone	NULL
(	NULL
GH	NULL
)	NULL
assay	NULL
(	NULL
Selden	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
HS-40-directed	NULL
{	NULL
2-globin	NULL
promoter	NULL
activities	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
HS-40-directed	NULL
a-globin	NULL
promoter	NULL
activities	NULL
in	NULL
Me	NULL
,	NULL
SO-induced	NULL
MEL	NULL
cells	NULL
were	NULL
measured	NULL
by	NULL
the	NULL
GH	NULL
assay	NULL
and/or	NULL
RNA	NULL
primer	NULL
extension	NULL
(	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
which	NULL
gave	NULL
comparable	NULL
results	NULL
.	NULL

Data	NULL
from	NULL
either	NULL
GH	NULL
assay	NULL
or	NULL
RNA	NULL
primer	NULL
extension	NULL
analysis	NULL
were	NULL
calibrated	NULL
against	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
activities	NULL
expressed	NULL
from	NULL
co-transfected	NULL
pSV2CAT	NULL
plasmids	NULL
(	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
)	NULL
,	NULL
although	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
activities	NULL
usually	NULL
were	NULL
constant	NULL
within	NULL
the	NULL
range	NULL
of	NULL
+10	NULL
%	NULL
.	NULL

The	NULL
quantities	NULL
of	NULL
the	NULL
endogenous	NULL
£2	NULL
mRNAs	NULL
were	NULL
also	NULL
used	NULL
to	NULL
standardize	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
transfected	NULL
plasmids	NULL
.	NULL

The	NULL
average	NULL
expression	NULL
level	NULL
for	NULL
each	NULL
plasmid	NULL
was	NULL
derived	NULL
from	NULL
three	NULL
or	NULL
more	NULL
independent	NULL
DNA	NULL
transfection	NULL
experiments	NULL
.	NULL

The	NULL
details	NULL
of	NULL
the	NULL
above	NULL
GH	NULL
assay	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
assay	NULL
,	NULL
and	NULL
RNA	NULL
primer	NULL
extension	NULL
analysis	NULL
are	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

RESULTS	NULL
The	NULL
HS-40	NULL
enhancer	NULL
consists	NULL
of	NULL
a	NULL
total	NULL
of	NULL
four	NULL
GATA-1	NULL
motifs	NULL
,	NULL
two	NULL
NF-E2/AP1	NULL
motifs	NULL
,	NULL
and	NULL
one	NULL
GT	NULL
motif	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
nuclear	NULL
factor	NULL
binding	NULL
studies	NULL
in	NULL
vitro	NULL
(	NULL
Jarman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Strauss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Except	NULL
for	NULL
GATA-l	NULL
(	NULL
a	NULL
)	NULL
,	NULL
which	NULL
exhibited	NULL
no	NULL
genomic	NULL
footprint	NULL
and	NULL
was	NULL
apparently	NULL
non-func-tional	NULL
in	NULL
previous	NULL
Bal31	NULL
deletion	NULL
analysis	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
we	NULL
have	NULL
introduced	NULL
2-	NULL
or	NULL
3-bp	NULL
substitutions	NULL
into	NULL
each	NULL
of	NULL
the	NULL
above	NULL
mentioned	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
enhancer	NULL
effects	NULL
of	NULL
these	NULL
HS-40	NULL
mutants	NULL
on	NULL
the	NULL
{	NULL
2-globin	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
on	NULL
the	NULL
-globin	NULL
promoter	NULL
activity	NULL
in	NULL
Me	NULL
,	NULL
SO-induced	NULL
MEL	NULL
cells	NULL
were	NULL
then	NULL
measured	NULL
by	NULL
transient	NULL
expression	NULL
assay	NULL
.	NULL

Under	NULL
our	NULL
experimental	NULL
conditions	NULL
,	NULL
the	NULL
wild	NULL
type	NULL
HS-40	NULL
enhances	NULL
the	NULL
activity	NULL
of	NULL
cis-linked	NULL
embryonic	NULL
{	NULL
2-globin	NULL
promoter	NULL
in	NULL
K562	NULL
cells	NULL
by	NULL
160	NULL
+	NULL
15-fold	NULL
and	NULL
that	NULL
of	NULL
cis-linked	NULL
adult	NULL
-globin	NULL
promoter	NULL
in	NULL
Me	NULL
,	NULL
SO-induced	NULL
MEL	NULL
cells	NULL
by	NULL
13	NULL
+	NULL
2-fold	NULL
.	NULL

As	NULL
exemplified	NULL
by	NULL
the	NULL
primer	NULL
extension	NULL
analysis	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
HS-40	NULL
on	NULL
(	NULL
2-globin	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
mutations	NULL
either	NULL
in	NULL
the	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
result	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
or	NULL
in	NULL
the	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
HS-40	NULL
enhancer	NULL
function	NULL
dropped	NULL
by	NULL
40	NULL
%	NULL
when	NULL
the	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
motif	NULL
was	NULL
mutated	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
5'NF-E2/AP1	NULL
or	NULL
GT	NULL
II	NULL
motif	NULL
essentially	NULL
abolished	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
HS-40	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
mutant	NULL
HS-40	NULL
with	NULL
the	NULL
1-bp	NULL
mutation	NULL
in	NULL
the	NULL
3'NF-E2/AP1	NULL
motif	NULL
,	NULL
3	NULL
'	NULL
(	NULL
NF-E2/AP1	NULL
)	NULL
-II	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
exhibited	NULL
a	NULL
2-3-fold	NULL
higher	NULL
level	NULL
of	NULL
enhancer	NULL
activity	NULL
than	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
3	NULL
and	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
previous	NULL
observation	NULL
of	NULL
similar	NULL
base	NULL
mutation	NULL
in	NULL
a	NULL
dimeric	NULL
NF-E2/AP1	NULL
motif	NULL
,	NULL
which	NULL
greatly	NULL
repressed	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
5HS2	NULL
or	NULL
B-LCR	NULL
(	NULL
see	NULL
``	NULL
Discussion	NULL
``	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
3-bp	NULL
mutation	NULL
of	NULL
3'NF-E2/AP1	NULL
motif	NULL
,	NULL
3	NULL
'	NULL
(	NULL
NF-E2/AP1	NULL
)	NULL
}	NULL
-I	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
greatly	NULL
decreased	NULL
the	NULL
HS-40	NULL
enhancer	NULL
Positive	NULL
and	NULL
Negative	NULL
Control	NULL
of	NULL
Human	NULL
«	NULL
-Globin	NULL
Enhancer	NULL
HS-40	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
of	NULL
HS-40	NULL
.	NULL

The	NULL
motifs	NULL
that	NULL
bind	NULL
nuclear	NULL
factors	NULL
in	NULL
vitro	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
blank	NULL
boxes	NULL
on	NULL
the	NULL
left	NULL
map	NULL
.	NULL

Those	NULL
motifs	NULL
that	NULL
bind	NULL
nuclear	NULL
factors	NULL
in	NULL
vivo	NULL
in	NULL
K562	NULL
cells	NULL
A	NULL
GATA	NULL
/API	NULL
GT	NULL
GATA	NULL
4	NULL
\	NULL
Fabs	NULL
Nera	NULL
--	NULL
--	NULL
-KRR4240	NULL
--	NULL
®	NULL
GATA	NULL
/APL	NULL
GT	NULL
GATA	NULL
4	NULL
\	NULL
2	NULL
%	NULL
8503	NULL
(	NULL
K	NULL
)	NULL
and	NULL
human	NULL
adult	NULL
erythroblasts	NULL
(	NULL
E	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
filled	NULL
or	NULL
hatched	NULL
boxes	NULL
.	NULL

Genomic	NULL
footprints	NULL
are	NULL
similar	NULL
for	NULL
motifs	NULL
with	NULL
filled	NULL
boxes	NULL
,	NULL
while	NULL
those	NULL
of	NULL
the	NULL
hatched	NULL
motifs	NULL
are	NULL
different	NULL
between	NULL
the	NULL
B	NULL
two	NULL
types	NULL
of	NULL
erythroid	NULL
cells	NULL
.	NULL

The	NULL
three	NULL
GATA-1	NULL
motifs	NULL
shown	NULL
are	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
,	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
,	NULL
and	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
5	NULL
'	NULL
-A	NULL
.	NULL

%	NULL
TG-3	NULL
'	NULL
as	NULL
arranged	NULL
on	NULL
HS-40	NULL
from	NULL
left	NULL
to	NULL
right	NULL
.	NULL

3'-TCG	NULL
AC-5	NULL
'	NULL
The	NULL
two	NULL
NF-E2/AP1	NULL
motifs	NULL
are	NULL
5'NF-E2/	NULL
AP1	NULL
and	NULL
3'NF-E2/AP1	NULL
,	NULL
also	NULL
arranged	NULL
from	NULL
left	NULL
to	NULL
right	NULL
.	NULL

The	NULL
single	NULL
GT	NULL
motif	NULL
is	NULL
termed	NULL
GT	NULL
II	NULL
throughout	NULL
the	NULL
text	NULL
.	NULL

The	NULL
maps	NULL
are	NULL
constructed	NULL
from	NULL
the	NULL
data	NULL
of	NULL
references	NULL
(	NULL
Jarman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Strauss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

B	NULL
,	NULL
mutants	NULL
of	NULL
HS-40	NULL
motifs	NULL
.	NULL

The	NULL
mutations	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
of	NULL
HS-40	NULL
were	NULL
generated	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

For	NULL
each	NULL
motif	NULL
and	NULL
its	NULL
flanking	NULL
DNA	NULL
,	NULL
the	NULL
wild	NULL
type	NULL
sequence	NULL
is	NULL
shown	NULL
in	NULL
full	NULL
,	NULL
with	NULL
the	NULL
central	NULL
binding	NULL
site	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
boxed	NULL
.	NULL

The	NULL
mutated	NULL
base	NULL
or	NULL
bases	NULL
are	NULL
indicated	NULL
by	NULL
downward	NULL
arrows	NULL
.	NULL

Note	NULL
that	NULL
two	NULL
different	NULL
mutants	NULL
of	NULL
the	NULL
3'NF-E2/AP1	NULL
motif	NULL
,	NULL
I	NULL
and	NULL
II	NULL
,	NULL
have	NULL
been	NULL
generated	NULL
and	NULL
analyzed	NULL
(	NULL
see	NULL
text	NULL
for	NULL
details	NULL
)	NULL
.	NULL

5	NULL
'NF-E2/AP1	NULL
3'NF-E2/APL-IL	NULL
-	NULL
5	NULL
3	NULL
'NF-E2/AP1-II	NULL
[	NULL
IGH-	NULL
»	NULL
(	NULL
64nt	NULL
)	NULL
»	NULL
NFE2	NULL
GATA-1	NULL
/APL	NULL
GT	NULL
GATA	NULL
#	NULL
*¥	NULL
FAbc	NULL
y*	NULL
Na	NULL
E	NULL
GT	NULL
II	NULL
*	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
PGATTACAA-	NULL
3	NULL
3	NULL
'-ACCACTAATETT-5	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
5'-TGTPTATCTBAG-3	NULL
'	NULL
AATAGACTC-5	NULL
'	NULL
vyy	NULL
v	NULL
v	NULL
T	NULL
G	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

A	NULL
,	NULL
example	NULL
of	NULL
primer	NULL
extension	NULL
assay	NULL
of	NULL
RNAs	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
plasmids	NULL
containing	NULL
{	NULL
2-GH	NULL
hybrid	NULL
gene	NULL
cis-linked	NULL
with	NULL
wild	NULL
type	NULL
HS-40	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
with	NULL
HS-40	NULL
enhancer	NULL
mutated	NULL
at	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
;	NULL
5'NF-E2/AP1	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
;	NULL
3'NF-E2/AP1	NULL
,	NULL
the	NULL
1-bp	NULL
mutation	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
;	NULL
GT	NULL
II	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
;	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
;	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
;	NULL
lane	NULL
8	NULL
is	NULL
from	NULL
enhancerless	NULL
plasmid	NULL
p-	NULL
{	NULL
597GH	NULL
.	NULL

B	NULL
,	NULL
primer	NULL
extension	NULL
assay	NULL
of	NULL
RNAs	NULL
from	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
plasmids	NULL
:	NULL
lane	NULL
1	NULL
,	NULL
wild	NULL
type	NULL
p-HS-40-597GH	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
lane	NULL
3	NULL
,	NULL
p-	NULL
{	NULL
597GH	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
p-HS-40	NULL
(	NULL
3'NF-E2/AP1-I	NULL
)	NULL
-	NULL
{	NULL
597GH	NULL
.	NULL

The	NULL
endogenous	NULL
{	NULL
2-globin	NULL
mRNAs	NULL
gave	NULL
primer	NULL
extension	NULL
products	NULL
93	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
long	NULL
,	NULL
while	NULL
the	NULL
major	NULL
primer	NULL
extension	NULL
product	NULL
from	NULL
{	NULL
(	NULL
2-GH	NULL
hybrid	NULL
RNAs	NULL
of	NULL
transfected	NULL
plasmids	NULL
is	NULL
64	NULL
nucleotides	NULL
long	NULL
.	NULL

function	NULL
by	NULL
75	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

As	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
all	NULL
mutations	NULL
introduced	NULL
into	NULL
HS-40	NULL
greatly	NULL
decreased	NULL
its	NULL
enhancer	NULL
effect	NULL
on	NULL
the	NULL
-globin	NULL
promoter	NULL
activity	NULL
in	NULL
Me	NULL
,	NULL
SO-induced	NULL
MEL	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
increase	NULL
of	NULL
HS-40	NULL
enhancer	NULL
function	NULL
in	NULL
K562	NULL
cells	NULL
due	NULL
to	NULL
the	NULL
3'NF-E2/AP1-II	NULL
mutation	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

Also	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
motif	NULL
,	NULL
which	NULL
is	NULL
genomic	NULL
footprinted	NULL
only	NULL
in	NULL
the	NULL
adult	NULL
erythroid	NULL
environment	NULL
(	NULL
Strauss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
decreased	NULL
the	NULL
HS-40	NULL
enhancer	NULL
function	NULL
in	NULL
MEL	NULL
cells	NULL
by	NULL
60	NULL
%	NULL
.	NULL

DISCUSSION	NULL
For	NULL
the	NULL
first	NULL
time	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
has	NULL
been	NULL
used	NULL
to	NULL
systematically	NULL
analyze	NULL
the	NULL
functional	NULL
roles	NULL
of	NULL
different	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
of	NULL
HS-40	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
human	NULL
«	NULL
-like	NULL
globin	NULL
upstream	NULL
promoters	NULL
by	NULL
the	NULL
«	NULL
-LCR	NULL
in	NULL
erythroid	NULL
cells	NULL
at	NULL
different	NULL
developmental	NULL
stages	NULL
.	NULL

Since	NULL
only	NULL
transient	NULL
expression	NULL
assay	NULL
has	NULL
been	NULL
used	NULL
,	NULL
our	NULL
data	NULL
most	NULL
likely	NULL
reflect	NULL
the	NULL
structure-function	NULL
relationship	NULL
during	NULL
the	NULL
final	NULL
stage	NULL
of	NULL
transcriptional	NULL
activation	NULL
when	NULL
the	NULL
globin	NULL
promoters	NULL
are	NULL
presumably	NULL
physically	NULL
associated	NULL
with	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

Our	NULL
primary	NULL
targets	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
HS-40	NULL
are	NULL
those	NULL
sequence	NULL
motifs	NULL
that	NULL
bind	NULL
specific	NULL
nuclear	NULL
factors	NULL
in	NULL
vitro	NULL
and/or	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
fact	NULL
that	NULL
genomic	NULL
footprints	NULL
most	NULL
likely	NULL
reflect	NULL
only	NULL
relatively	NULL
stable	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
DNA	NULL
helix	NULL
and	NULL
that	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
functioning	NULL
at	NULL
an	NULL
earlier	NULL
stage	NULL
of	NULL
human	NULL
«	NULL
-like	NULL
globin	NULL
gene	NULL
regulation	NULL
may	NULL
remain	NULL
bound	NULL
to	NULL
its	NULL
cognate	NULL
DNA	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
,	NULL
our	NULL
data	NULL
have	NULL
demonstrated	NULL
a	NULL
remarkable	NULL
correlation	NULL
between	NULL
the	NULL
erythroid-specific	NULL
occupancy	NULL
of	NULL
specific	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
at	NULL
the	NULL
HS-40	NULL
enhancer	NULL
and	NULL
their	NULL
regulatory	NULL
roles	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
«	NULL
-like	NULL
globin	NULL
promoters	NULL
in	NULL
transiently	NULL
transfected	NULL
erythroid	NULL
cell	NULL
cultures	NULL
.	NULL

Positive	NULL
Regulatory	NULL
and	NULL
Neutral	NULL
Roles	NULL
of	NULL
Different	NULL
GATA-1	NULL
Motifs-Several	NULL
previous	NULL
studies	NULL
have	NULL
analyzed	NULL
the	NULL
function	NULL
of	NULL
the	NULL
single	NULL
GATA-1	NULL
motif	NULL
in	NULL
the	NULL
5'HS-2	NULL
enhancer	NULL
of	NULL
B-LCR	NULL
.	NULL

Mutation	NULL
in	NULL
the	NULL
GATA-1	NULL
motif	NULL
of	NULL
a	NULL
synthetic	NULL
core	NULL
5'HS-2	NULL
fragment	NULL
showed	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
a	NULL
linked	NULL
human	NULL
globin	NULL
gene	NULL
in	NULL
multicopy	NULL
transgenic	NULL
mice	NULL
(	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
same	NULL
construct	NULL
exhibited	NULL
a	NULL
40	NULL
%	NULL
reduction	NULL
of	NULL
B-glo-bin	NULL
gene	NULL
expression	NULL
in	NULL
stably	NULL
integrated	NULL
MEL	NULL
cells	NULL
(	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
same	NULL
GATA-1	NULL
motif	NULL
in	NULL
a	NULL
native	NULL
5'HS-2	NULL
environment	NULL
,	NULL
however	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
cis-linked	NULL
y-globin	NULL
promoter	NULL
when	NULL
stably	NULL
integrated	NULL
in	NULL
K562	NULL
cells	NULL
as	NULL
a	NULL
single	NULL
copy	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
GATA-1	NULL
mutation	NULL
8504	NULL
Positive	NULL
and	NULL
Negative	NULL
Control	NULL
of	NULL
Human	NULL
«	NULL
-Globin	NULL
Enhancer	NULL
HS-40	NULL
178-182	NULL
16-21	NULL
111-116	NULL
129-137	NULL
-	NULL
160-168	NULL
217-222	NULL
252-257	NULL
1	NULL
L2	NULL
0	NULL
EZ	NULL
nan	NULL
ake	NULL
as	NULL
__	NULL
__0_________	NULL
B	NULL
#	NULL
_	NULL
BR	NULL
Z	NULL
OB	NULL
L	NULL
1	NULL
ley	NULL
snuances	NULL
GATA-1	NULL
GATA-1	NULL
SNF-E2	NULL
3NF-E2	NULL
GT	NULL
GATA-1	NULL
GATA-1	NULL
l	NULL
(	NULL
a	NULL
)	NULL
(	NULL
b	NULL
)	NULL
_	NULL
/APL	NULL
_	NULL
APL	NULL
II	NULL
(	NULL
€	NULL
)	NULL
(	NULL
d	NULL
)	NULL
STRENGTHS	NULL
-	NULL
@	NULL
/MEL	NULL
wT	NULL
]	NULL
100	NULL
100	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
x	NULL
H	NULL
110	NULL
(	NULL
7	NULL
)	NULL
20	NULL
(	NULL
3	NULL
)	NULL
5'NF-E2/AP1	NULL
x	NULL
}	NULL
5	NULL
(	NULL
1	NULL
)	NULL
20	NULL
(	NULL
1	NULL
)	NULL
3	NULL
'	NULL
(	NULL
NF-EZ/AP1	NULL
)	NULL
-I	NULL
x	NULL
{	NULL
25	NULL
(	NULL
10	NULL
)	NULL
15	NULL
(	NULL
5	NULL
)	NULL
3	NULL
'	NULL
(	NULL
NF-E2/AP1	NULL
)	NULL
-1I	NULL
x	NULL
lj	NULL
240	NULL
(	NULL
60	NULL
)	NULL
20	NULL
(	NULL
4	NULL
)	NULL
ST	NULL
u	NULL
x	NULL
I+	NULL
1503	NULL
)	NULL
30	NULL
(	NULL
5	NULL
)	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
x	NULL
{	NULL
60	NULL
(	NULL
2	NULL
)	NULL
10	NULL
(	NULL
1	NULL
)	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
x	NULL
H	NULL
90	NULL
(	NULL
4	NULL
)	NULL
40	NULL
(	NULL
2	NULL
)	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Summary	NULL
of	NULL
functional	NULL
roles	NULL
of	NULL
individual	NULL
nuclear	NULL
factor	NULL
binding	NULL
motifs	NULL
of	NULL
HS-40	NULL
enhancer	NULL
.	NULL

The	NULL
motifs	NULL
in	NULL
the	NULL
355-bp	NULL
enhancer	NULL
are	NULL
labeled	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
except	NULL
for	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
,	NULL
which	NULL
is	NULL
half-filled	NULL
to	NULL
indicate	NULL
its	NULL
occupancy	NULL
by	NULL
nuclear	NULL
factors	NULL
,	NULL
presumably	NULL
GATA-1	NULL
,	NULL
in	NULL
adult	NULL
erythroid	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

The	NULL
small	NULL
x	NULL
in	NULL
the	NULL
lines	NULL
below	NULL
the	NULL
top	NULL
diagram	NULL
indicates	NULL
the	NULL
individual	NULL
motifs	NULL
changed	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

The	NULL
enhancer	NULL
effects	NULL
of	NULL
wild	NULL
type	NULL
and	NULL
mutant	NULL
HS-40	NULL
sequences	NULL
on	NULL
the	NULL
£2-globin	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
on	NULL
the	NULL
a-globin	NULL
promoter	NULL
in	NULL
Me	NULL
,	NULL
SO-induced	NULL
MEL	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
transient	NULL
expression	NULL
assay	NULL
.	NULL

The	NULL
relative	NULL
enhancer	NULL
strengths	NULL
,	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
WT	NULL
)	NULL
HS-40	NULL
being	NULL
100	NULL
%	NULL
,	NULL
were	NULL
calculated	NULL
from	NULL
RNA	NULL
primer	NULL
extension	NULL
and	NULL
GH	NULL
assay	NULL
data	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
and	NULL
are	NULL
listed	NULL
.	NULL

The	NULL
standard	NULL
deviations	NULL
,	NULL
as	NULL
derived	NULL
from	NULL
two	NULL
to	NULL
four	NULL
independent	NULL
transfection	NULL
experiments	NULL
,	NULL
are	NULL
listed	NULL
in	NULL
the	NULL
parentheses	NULL
.	NULL

showed	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
5HS-2	NULL
enhancer	NULL
function	NULL
on	NULL
e-globin	NULL
promoter	NULL
in	NULL
transiently	NULL
transfected	NULL
K562	NULL
cells	NULL
(	NULL
Gong	NULL
and	NULL
Dean	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

It	NULL
was	NULL
suggested	NULL
by	NULL
these	NULL
workers	NULL
that	NULL
GATA-1	NULL
motif	NULL
may	NULL
function	NULL
by	NULL
conferring	NULL
position-independent	NULL
expression	NULL
of	NULL
linked	NULL
genes	NULL
,	NULL
instead	NULL
of	NULL
acting	NULL
as	NULL
a	NULL
classical	NULL
enhancer	NULL
element	NULL
.	NULL

However	NULL
,	NULL
interpretation	NULL
of	NULL
the	NULL
above	NULL
data	NULL
was	NULL
complicated	NULL
by	NULL
5'HS-2	NULL
being	NULL
only	NULL
a	NULL
part	NULL
of	NULL
the	NULL
B-LCR	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
at	NULL
least	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
final	NULL
stage	NULL
of	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
«	NULL
-like	NULL
globin	NULL
promoters	NULL
by	NULL
HS-40	NULL
in	NULL
embryonic/fetal	NULL
as	NULL
well	NULL
as	NULL
in	NULL
adult	NULL
erythroid	NULL
cells	NULL
,	NULL
although	NULL
the	NULL
effect	NULL
of	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
mutation	NULL
on	NULL
HS-40	NULL
enhancer-directed	NULL
activation	NULL
of	NULL
the	NULL
{	NULL
2-globin	NULL
promoter	NULL
in	NULL
K562	NULL
cells	NULL
is	NULL
not	NULL
as	NULL
great	NULL
as	NULL
the	NULL
GT	NULL
II	NULL
or	NULL
NF-E2/AP1	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
;	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
mutation	NULL
of	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
motif	NULL
,	NULL
which	NULL
is	NULL
bound	NULL
with	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
adult	NULL
erythroid	NULL
environment	NULL
but	NULL
not	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
Strauss	NULL
et	NULL
ol	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
indeed	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
HS-40	NULL
enhancer	NULL
function	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
involved	NULL
,	NULL
however	NULL
,	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
a-globin	NULL
promoter	NULL
by	NULL
HS-40	NULL
in	NULL
transiently	NULL
transfected	NULL
MEL	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
above	NULL
three	NULL
GATA-1	NULL
mutations	NULL
would	NULL
prohibit	NULL
binding	NULL
of	NULL
the	NULL
GATA-1	NULL
factor	NULL
(	NULL
Ko	NULL
and	NULL
Engel	NULL
,	NULL
1993	NULL
)	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
formed	NULL
at	NULL
the	NULL
GATA-1	NULL
(	NULL
c	NULL
)	NULL
and	NULL
GATA-1	NULL
(	NULL
d	NULL
)	NULL
motifs	NULL
play	NULL
active	NULL
roles	NULL
in	NULL
the	NULL
erythroid	NULL
cell-specific	NULL
and	NULL
developmental	NULL
stage-specific	NULL
enhancer	NULL
function	NULL
of	NULL
the	NULL
HS-40	NULL
or	NULL
«	NULL
-LCR	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
mutation	NULL
in	NULL
the	NULL
GATA-1	NULL
(	NULL
b	NULL
)	NULL
motif	NULL
,	NULL
which	NULL
is	NULL
occupied	NULL
by	NULL
nuclear	NULL
factors	NULL
in	NULL
both	NULL
K562	NULL
cells	NULL
and	NULL
adult	NULL
erythroblasts	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
showed	NULL
no	NULL
effect	NULL
in	NULL
transfected	NULL
K562	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

We	NULL
suspect	NULL
that	NULL
in	NULL
erythroid	NULL
cells	NULL
of	NULL
embryonic/fetal	NULL
lineage	NULL
such	NULL
as	NULL
K562	NULL
,	NULL
this	NULL
GATA-1	NULL
motif	NULL
is	NULL
involved	NULL
at	NULL
an	NULL
earlier	NULL
regulatory	NULL
step	NULL
of	NULL
HS-40	NULL
function	NULL
such	NULL
as	NULL
the	NULL
assembly	NULL
of	NULL
an	NULL
active	NULL
chromatin	NULL
structure	NULL
.	NULL

The	NULL
GT	NULL
II	NULL
Motif	NULL
Is	NULL
Essential	NULL
for	NULL
HS-40	NULL
Enhancer	NULL
Function-The	NULL
function	NULL
of	NULL
the	NULL
GT	NULL
motif	NULL
of	NULL
5'HS-2	NULL
of	NULL
the	NULL
B-LCR	NULL
has	NULL
been	NULL
analyzed	NULL
previously	NULL
.	NULL

Its	NULL
mutation	NULL
has	NULL
only	NULL
a	NULL
minimal	NULL
effect	NULL
on	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
either	NULL
a	NULL
synthetic	NULL
5'HS-2	NULL
fragment	NULL
in	NULL
stably	NULL
integrated	NULL
cells	NULL
(	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
or	NULL
a	NULL
native	NULL
5'HS-2	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
Caterina	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
drastic	NULL
decrease	NULL
in	NULL
the	NULL
enhancer	NULL
effect	NULL
of	NULL
HS-40	NULL
carrying	NULL
a	NULL
mutation	NULL
in	NULL
its	NULL
GT	NULL
motif	NULL
,	NULL
GT	NULL
II	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
strongly	NULL
suggests	NULL
that	NULL
the	NULL
nuclear	NULL
factor-DNA	NULL
complex	NULL
(	NULL
es	NULL
)	NULL
at	NULL
the	NULL
GT	NULL
motif	NULL
is	NULL
an	NULL
essential	NULL
and	NULL
integral	NULL
part	NULL
of	NULL
the	NULL
multiple	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
in	NULL
HS-40	NULL
during	NULL
its	NULL
final	NULL
step	NULL
of	NULL
activating	NULL
the	NULL
-like	NULL
globin	NULL
promoters	NULL
in	NULL
erythroid	NULL
cells	NULL
of	NULL
different	NULL
developmental	NULL
stages	NULL
.	NULL

Spl	NULL
is	NULL
the	NULL
major	NULL
protein	NULL
in	NULL
K562	NULL
nuclear	NULL
extract	NULL
that	NULL
binds	NULL
the	NULL
wild	NULL
type	NULL
HS-40	NULL
GT	NULL
motif	NULL
.	NULL

However	NULL
,	NULL
it	NULL
can	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
mutant	NULL
GT	NULL
motif	NULL
.	NULL
``	NULL

The	NULL
close	NULL
proximity	NULL
of	NULL
GT	NULL
II	NULL
to	NULL
the	NULL
3'NF-E2	NULL
%	NULL
/AP1	NULL
motif	NULL
also	NULL
implies	NULL
that	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
formed	NULL
at	NULL
these	NULL
two	NULL
motifs	NULL
may	NULL
directly	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
.	NULL

Positive	NULL
and	NULL
Negative	NULL
Regulatory	NULL
Roles	NULL
of	NULL
the	NULL
NF-E2/AP1	NULL
Motifs-The	NULL
function	NULL
of	NULL
the	NULL
tandemly	NULL
arranged	NULL
,	NULL
dimeric	NULL
NF-E2/AP1	NULL
motifs	NULL
of	NULL
5'HS-2	NULL
of	NULL
the	NULL
B-LCR	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
previously	NULL
by	NULL
the	NULL
analysis	NULL
of	NULL
mutated	NULL
5HS-2	NULL
or	NULL
B-LCR	NULL
in	NULL
transiently	NULL
transfected	NULL
cells	NULL
,	NULL
in	NULL
stably	NULL
integrated	NULL
cell	NULL
lines	NULL
,	NULL
or	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

These	NULL
results	NULL
have	NULL
demonstrated	NULL
that	NULL
intact	NULL
dimeric	NULL
NF-E2/AP1	NULL
motifs	NULL
are	NULL
required	NULL
for	NULL
5HS-2	NULL
to	NULL
function	NULL
as	NULL
a	NULL
potent	NULL
erythroid-specific	NULL
enhancer	NULL
.	NULL

However	NULL
,	NULL
the	NULL
dimer	NULL
motifs	NULL
do	NULL
not	NULL
play	NULL
any	NULL
role	NULL
in	NULL
B-LCR	NULL
or	NULL
5HS-2-mediated	NULL
,	NULL
integration	NULL
site-independent	NULL
expression	NULL
of	NULL
different	NULL
human	NULL
B-like	NULL
globin	NULL
promoters	NULL
(	NULL
Moi	NULL
and	NULL
Kan	NULL
,	NULL
1990	NULL
;	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19902	NULL
,	NULL
1990b	NULL
;	NULL
Caterina	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Talbot	NULL
and	NULL
Grosveld	NULL
,	NULL
1991	NULL
;	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19983	NULL
)	NULL
.	NULL

The	NULL
NF-E2	NULL
%	NULL
/AP1	NULL
binding	NULL
domain	NULL
of	NULL
HS-40	NULL
consists	NULL
of	NULL
two	NULL
motifs	NULL
separated	NULL
by	NULL
6	NULL
bp	NULL
,	NULL
5	NULL
!	NULL

-ATGACTCAGTG-3	NULL
'	NULL
and	NULL
5-TGCT-GAGTCAT-3	NULL
'	NULL
,	NULL
both	NULL
of	NULL
which	NULL
can	NULL
bind	NULL
NF-E2	NULL
as	NULL
well	NULL
as	NULL
AP1	NULL
(	NULL
Jarman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Strauss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Andrews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
)	NULL
.	NULL

As	NULL
we	NULL
have	NULL
discovered	NULL
,	NULL
contrasting	NULL
with	NULL
5'HS-2	NULL
,	NULL
the	NULL
NF-E2/AP1	NULL
motifs	NULL
of	NULL
the	NULL
«	NULL
-LCR	NULL
,	NULL
or	NULL
HS-40	NULL
,	NULL
can	NULL
function	NULL
as	NULL
either	NULL
a	NULL
positive	NULL
or	NULL
negative	NULL
regulatory	NULL
element	NULL
,	NULL
Introduction	NULL
of	NULL
a	NULL
3-bp	NULL
mutation	NULL
into	NULL
the	NULL
central	NULL
core	NULL
of	NULL
either	NULL
the	NULL
5	NULL
or	NULL
3	NULL
'	NULL
NF-E2/AP1	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
significantly	NULL
lowered	NULL
the	NULL
HS-40	NULL
enhancer	NULL
function	NULL
to	NULL
5-25	NULL
%	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
level	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
a	NULL
GC	NULL
base	NULL
pair	NULL
at	NULL
one	NULL
boundary	NULL
of	NULL
the	NULL
3'NF-E2/AP1	NULL
binding	NULL
site	NULL
is	NULL
changed	NULL
to	NULL
TA	NULL
(	NULL
3	NULL
'	NULL
(	NULL
NF-E2Z/AP1	NULL
)	NULL
-II	NULL
,	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
,	NULL
when	NULL
placed	NULL
in	NULL
the	NULL
genomic	NULL
orientation	NULL
relative	NULL
to	NULL
the	NULL
{	NULL
2-globin	NULL
promoter	NULL
in	NULL
the	NULL
plasmid	NULL
,	NULL
is	NULL
increased	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
2-3-fold	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
interesting	NULL
since	NULL
extensive	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
same	NULL
1-bp	NULL
mutation	NULL
abolishes	NULL
the	NULL
binding	NULL
of	NULL
NF-E2	NULL
,	NULL
but	NULL
not	NULL
API	NULL
,	NULL
to	NULL
the	NULL
sequence	NULL
(	NULL
5-GCTGAGTCAT-3/3'-CGACTCAGTA-S	NULL
'	NULL
)	NULL
,	NULL
which	NULL
is	NULL
identical	NULL
in	NULL
the	NULL
5'NF-E2/AP1	NULL
motif	NULL
of	NULL
the	NULL
5HS-2	NULL
2	NULL
(	NULL
i.	NULL
N.	NULL
Reddy	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

Positive	NULL
and	NULL
Negative	NULL
Control	NULL
of	NULL
Human	NULL
«	NULL
-Globin	NULL
Enhancer	NULL
HS-40	NULL
enhancer	NULL
,	NULL
3'NF-E2/AP1	NULL
motif	NULL
of	NULL
HS-40	NULL
,	NULL
and	NULL
the	NULL
NF-E2/AP1	NULL
site	NULL
in	NULL
the	NULL
porphobilinogen	NULL
deaminase	NULL
promoter	NULL
(	NULL
Mignotte	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Moi	NULL
and	NULL
Kan	NULL
,	NULL
1990	NULL
;	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990b	NULL
;	NULL
Talbot	NULL
and	NULL
Grosveld	NULL
,	NULL
1991	NULL
;	NULL
Andrews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
;	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
3-bp	NULL
mutation	NULL
would	NULL
greatly	NULL
affect	NULL
the	NULL
binding	NULL
of	NULL
both	NULL
NF-E2	NULL
(	NULL
3	NULL
)	NULL
and	NULL
AP1	NULL
(	NULL
Smeal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Abate	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
opposite	NULL
effects	NULL
of	NULL
the	NULL
3-	NULL
and	NULL
1-bp	NULL
mutations	NULL
of	NULL
the	NULL
3'NF-E2/AP1	NULL
motif	NULL
thus	NULL
strongly	NULL
suggest	NULL
that	NULL
binding	NULL
of	NULL
NF-E2	NULL
factor	NULL
to	NULL
the	NULL
3'NF-E2/AP1	NULL
motif	NULL
,	NULL
and	NULL
possibly	NULL
the	NULL
5'NF-E2/AP1	NULL
motif	NULL
as	NULL
well	NULL
,	NULL
represses	NULL
the	NULL
HS-40-mediated	NULL
£2-globin	NULL
promoter	NULL
activity	NULL
,	NULL
while	NULL
the	NULL
binding	NULL
of	NULL
other	NULL
AP1	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
same	NULL
motif	NULL
(	NULL
s	NULL
)	NULL
positively	NULL
regulates	NULL
the	NULL
HS-40	NULL
function	NULL
on	NULL
£2	NULL
promoter	NULL
expression	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

Given	NULL
that	NULL
K562	NULL
is	NULL
an	NULL
erythroid	NULL
cell	NULL
line	NULL
trapped	NULL
during	NULL
the	NULL
embryonic	NULL
to	NULL
fetal	NULL
transition	NULL
(	NULL
Lozzio	NULL
and	NULL
Lozzio	NULL
,	NULL
1975	NULL
)	NULL
and	NULL
the	NULL
relative	NULL
concentration	NULL
of	NULL
NF-E2	NULL
to	NULL
AP1	NULL
in	NULL
erythroid	NULL
cells	NULL
appears	NULL
to	NULL
increase	NULL
as	NULL
development	NULL
proceeds	NULL
(	NULL
Andrews	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
transcriptional	NULL
activation	NULL
and	NULL
silencing	NULL
of	NULL
the	NULL
human	NULL
£2-globin	NULL
gene	NULL
during	NULL
embryonic	NULL
to	NULL
fetal	NULL
erythroid	NULL
development	NULL
is	NULL
partly	NULL
modulated	NULL
by	NULL
the	NULL
competitive	NULL
binding	NULL
of	NULL
positive	NULL
regulatory	NULL
AP1	NULL
and	NULL
negative	NULL
regulatory	NULL
NF-E2	NULL
factors	NULL
to	NULL
the	NULL
«	NULL
-LCR	NULL
.	NULL

Of	NULL
course	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
other	NULL
nuclear	NULL
factors	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
NF-E2/AP1	NULL
motif	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
HS-40	NULL
enhancer	NULL
effect	NULL
(	NULL
Chan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Caterina	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Igarashi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Kataoka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Kerppola	NULL
and	NULL
Curran	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
apparent	NULL
negative	NULL
regulatory	NULL
effect	NULL
of	NULL
NF-E2	NULL
binding	NULL
on	NULL
the	NULL
HS-40	NULL
enhancer-directed	NULL
expression	NULL
of	NULL
{	NULL
2-globin	NULL
promoter	NULL
activity	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
negative	NULL
regulation	NULL
of	NULL
several	NULL
non-erythroid	NULL
eukaryotic	NULL
gene	NULL
systems	NULL
mediated	NULL
through	NULL
binding	NULL
of	NULL
the	NULL
c-Fos-c-Jun	NULL
complex	NULL
at	NULL
AP1	NULL
binding	NULL
sites	NULL
(	NULL
Nicholson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Lopez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Hsu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
known	NULL
that	NULL
specific	NULL
nuclear	NULL
factor	NULL
binding	NULL
DNA	NULL
motifs	NULL
)	NULL
can	NULL
function	NULL
as	NULL
either	NULL
a	NULL
positive	NULL
or	NULL
negative	NULL
regulatory	NULL
element	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cellular	NULL
environment	NULL
(	NULL
Miner	NULL
and	NULL
Yamamoto	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
an	NULL
enhancer	NULL
could	NULL
sometimes	NULL
function	NULL
as	NULL
a	NULL
silencer	NULL
(	NULL
Jiang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

REFERENCES	NULL
Abate	NULL
,	NULL
C.	NULL
,	NULL
Luk	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
3624-3632	NULL
Albitar	NULL
,	NULL
M.	NULL
,	NULL
Peschle	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Liebhaber	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
629-637	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Erdjument-Bromage	NULL
,	NULL
H.	NULL
,	NULL
Davison	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
19932	NULL
)	NULL
Nature	NULL
362	NULL
,	NULL
722-728	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Kotkow	NULL
,	NULL
K.	NULL
,	NULL
Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Erdjument-Bromage	NULL
,	NULL
H.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1993b	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11871-11375	NULL
Baron	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
591-602	NULL
Caterina	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Ryan	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Pawlick	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Palmiter	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Brinster	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Behringer	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
Townes	NULL
,	NULL
T.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
1626-1630	NULL
Caterina	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Donze	NULL
,	NULL
D.	NULL
,	NULL
Sun	NULL
,	NULL
C.-W.	NULL
,	NULL
Ciavatta	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Townes	NULL
,	NULL
T.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12	NULL
,	NULL
2383-2391	NULL
Chan	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Han	NULL
,	NULL
X-L.	NULL
,	NULL
and	NULL
Kan	NULL
,	NULL
Y.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11371-11375	NULL
Chang	NULL
,	NULL
T.	NULL
Y.	NULL
,	NULL
Han	NULL
,	NULL
X.-L.	NULL
,	NULL
and	NULL
Kan	NULL
,	NULL
Y.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11366-11370	NULL
Chui	NULL
,	NULL
P.	NULL
H.	NULL
K.	NULL
,	NULL
Mentzer	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Patterson	NULL
,	NULL
M.	NULL
,	NULL
Larocci	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Embury	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Perrine	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Mibashan	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
1409-1414	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

81	NULL
,	NULL
315-421	NULL
Deisseroth	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hendrick	NULL
,	NULL
D.	NULL
(	NULL
1979	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

76	NULL
,	NULL
8505	NULL
2185-2189	NULL
Ellis	NULL
,	NULL
J.	NULL
,	NULL
Talbot	NULL
,	NULL
D.	NULL
,	NULL
Dillon	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
129-134	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

9	NULL
,	NULL
304-309	NULL
Evans	NULL
,	NULL
T.	NULL
,	NULL
Felsenfeld	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Reitman	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6	NULL
,	NULL
95-124	NULL
Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Epner	NULL
,	NULL
E.	NULL
,	NULL
Driscoll	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Enver	NULL
,	NULL
T.	NULL
,	NULL
Brice	NULL
,	NULL
M.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1637-1649	NULL
Friend	NULL
,	NULL
C.	NULL
,	NULL
Scher	NULL
,	NULL
W.	NULL
,	NULL
Holland	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
Sato	NULL
,	NULL
T.	NULL
(	NULL
1971	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

68	NULL
,	NULL
378-382	NULL
Gong	NULL
,	NULL
Q.	NULL
,	NULL
and	NULL
Dean	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
911-917	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
Gourdon	NULL
,	NULL
G.	NULL
,	NULL
Sharpe	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Wells	NULL
,	NULL
D.	NULL
,	NULL
Wood	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
and	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
4139-4147	NULL
Grosveld	NULL
,	NULL
F.	NULL
,	NULL
Van	NULL
Assendelft	NULL
,	NULL
G.	NULL
B.	NULL
,	NULL
Greaves	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Kollias	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
975-985	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Vickers	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Wilkie	NULL
,	NULL
A.	NULL
O.	NULL
M.	NULL
,	NULL
Pretorius	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
Jarman	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
Weatherall	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Blood	NULL
73	NULL
,	NULL
1081-1104	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Wood	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
Jarman	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Sharpe	NULL
,	NULL
J.	NULL
,	NULL
Lida	NULL
,	NULL
J.	NULL
,	NULL
Pretorius	NULL
,	NULL
L-	NULL
M.	NULL
,	NULL
and	NULL
Ayyub	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1588-1601	NULL
Hsu	NULL
,	NULL
W.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Chen-Kiang	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
268-276	NULL
Igarashi	NULL
,	NULL
K.	NULL
,	NULL
Kataoka	NULL
,	NULL
K.	NULL
,	NULL
Itoh	NULL
,	NULL
K.	NULL
,	NULL
Hayashi	NULL
,	NULL
N.	NULL
,	NULL
Nishizawa	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
367	NULL
,	NULL
568-572	NULL
Jarman	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Wood	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
Sharpe	NULL
,	NULL
J.	NULL
,	NULL
Gourdon	NULL
,	NULL
G.	NULL
,	NULL
Ayyub	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4679-4689	NULL
Jiang	NULL
,	NULL
J.	NULL
,	NULL
Cai	NULL
,	NULL
H.	NULL
,	NULL
Zhou	NULL
,	NULL
Q.	NULL
,	NULL
and	NULL
Levine	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3201-3209	NULL
Karlsson	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

54	NULL
,	NULL
1071-1108	NULL
Kataoka	NULL
,	NULL
K.	NULL
,	NULL
Noda	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Nishizawa	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
,	NULL
Biol	NULL
.	NULL

14	NULL
,	NULL
700-712	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
675-684	NULL
Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
4011-4022	NULL
Lopez	NULL
,	NULL
G.	NULL
,	NULL
Schaufele	NULL
,	NULL
F.	NULL
,	NULL
Webb	NULL
,	NULL
P.	NULL
,	NULL
Holloway	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Baxter	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Kushner	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3042-3049	NULL
Lozzio	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Lozzio	NULL
,	NULL
B	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1975	NULL
)	NULL
Blood	NULL
45	NULL
,	NULL
821-334	NULL
Martin	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
Mutter	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
444-447	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Eleouet	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Raich	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Romeo	NULL
,	NULL
P.-H.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
6548-6552	NULL
Miller	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Walsh	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Samulski	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1900-1906	NULL
Miner	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

2	NULL
,	NULL
525-530	NULL
Moi	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Kan	NULL
,	NULL
Y	NULL
,	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
,	NULL
87	NULL
,	NULL
9000-9004	NULL
Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Sorrentino	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
McDonagh	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
993-1006	NULL
Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Sorrentino	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Lowrey	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1990b	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
6011-6017	NULL
Ney	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Jane	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Safer	NULL
,	NULL
B.	NULL
,	NULL
Purucker	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Weremowicz	NULL
,	NULL
S.	NULL
,	NULL
Morton	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Goff	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
5604-5612	NULL
Nicholson	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Mader	NULL
,	NULL
S.	NULL
,	NULL
Nagpal	NULL
,	NULL
S.	NULL
,	NULL
Leid	NULL
,	NULL
M.	NULL
,	NULL
Rochette-Egly	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
4443-4454	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
665-672	NULL
Pondel	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
George	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Proudfoot	NULL
,	NULL
N.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
237-243	NULL
Potter	NULL
,	NULL
H.	NULL
,	NULL
Weir	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

81	NULL
,	NULL
7161-7165	NULL
Reddy	NULL
,	NULL
S.	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
Shen	NULL
,	NULL
C.-K.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
1098-1103	NULL
Ren	NULL
,	NULL
S.	NULL
,	NULL
Luo	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Atweh	NULL
,	NULL
G.	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
1058-1066	NULL
Romeo	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Prandini	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Joulin	NULL
,	NULL
V.	NULL
,	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Prenant	NULL
,	NULL
M.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
Marguerie	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Uzan	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
447-449	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Selden	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Burke-howie	NULL
,	NULL
K.	NULL
,	NULL
Rowe	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Goodman	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
3173-3179	NULL
Sharpe	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Chan-Thomas	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Lida	NULL
,	NULL
J.	NULL
,	NULL
Ayyub	NULL
,	NULL
H.	NULL
,	NULL
Wood	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
and	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
4565-4572	NULL
Sharpe	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Wells	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Whitelaw	NULL
,	NULL
E.	NULL
,	NULL
Vyas	NULL
,	NULL
P.	NULL
,	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Wood	NULL
,	NULL
W.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11262-11266	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Meek	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
2091-2100	NULL
Stamatoyannopoulos	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
252	NULL
,	NULL
383	NULL
Strauss	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Andrews	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2185-2142	NULL
Talbot	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1391-1398	NULL
Tuan	NULL
,	NULL
D.	NULL
,	NULL
Soloman	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
London	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
D.	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
2554-2558	NULL
Vyas	NULL
,	NULL
P.	NULL
,	NULL
Sharpe	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Watt	NULL
,	NULL
P.	NULL
,	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Wood	NULL
,	NULL
W.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
1832-1837	NULL
Zhang	NULL
,	NULL
Q.	NULL
,	NULL
Reddy	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Yu	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
Bastiani	NULL
,	NULL
C.	NULL
,	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Stamatoyannopoulos	NULL
,	NULL
G.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Shen	NULL
,	NULL
C.-K.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
13	NULL
,	NULL
2298-1308	NULL

